Alexion’s Phase III Data Position Ultomiris For Expansion Into Myasthenia Gravis

 
• By Joseph Haas
  
Research scientist
Phase III data might put Alexion closer to adding myasthenia gravis to the Ultomiris label

More from Clinical Trials

More from R&D